SGLT2 inhibitor therapy and clinical outcomes in HIV-related cardiomyopathy.

Saved in:
Bibliographic Details
Title: SGLT2 inhibitor therapy and clinical outcomes in HIV-related cardiomyopathy.
Authors: Sheashaa H; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA., Ibrahim R; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA., Pham HN; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Medicine, University of Arizona, Tucson, AZ, USA., Awad K; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA., Scalia IG; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA., Farina JM; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA., Tamarappoo B; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA., Holloway C; Department of Cardiology, St Vincent's Hospital, Sydney, Australia., Arsanjani R; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA., Ayoub C; Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA.
Source: American heart journal plus : cardiology research and practice [Am Heart J Plus] 2026 Jan 14; Vol. 62, pp. 100722. Date of Electronic Publication: 2026 Jan 14 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101779333 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-6022 (Electronic) Linking ISSN: 26666022 NLM ISO Abbreviation: Am Heart J Plus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6022
DOI:10.1016/j.ahjo.2026.100722